NPFCX
Price
$61.25
Change
-$1.94 (-3.07%)
Updated
Dec 18 closing price
RNGCX
Price
$58.82
Change
-$2.11 (-3.46%)
Updated
Dec 18 closing price
Ad is loading...

NPFCX vs RNGCX

Header iconNPFCX vs RNGCX Comparison
Open Charts NPFCX vs RNGCXBanner chart's image
American Funds New Perspective C
Price$61.25
Change-$1.94 (-3.07%)
VolumeN/A
CapitalizationN/A
American Funds New Economy R3
Price$58.82
Change-$2.11 (-3.46%)
VolumeN/A
CapitalizationN/A
NPFCX vs RNGCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NPFCX vs. RNGCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NPFCX is a Buy and RNGCX is a Hold.

FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 149B vs. RNGCX (34.6B). NPFCX pays higher dividends than RNGCX: NPFCX (0.20) vs RNGCX (0.00). NPFCX was incepted earlier than RNGCX: NPFCX (24 years) vs RNGCX (23 years). RNGCX is a more actively managed with annual turnover of: 39.00 vs. NPFCX (17.00). NPFCX (250) and RNGCX (250) have matching initial minimum investment requirements. NPFCX annual gain was more profitable for investors over the last year : 22.22 vs. RNGCX (13.62). NPFCX return over 5 years is better than : 36.81 vs. RNGCX (32.09).
NPFCXRNGCXNPFCX / RNGCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years23 years-
Gain YTD20.63813.486153%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets149B34.6B431%
Annual Yield % from dividends0.200.00-
Returns for 1 year22.2213.62163%
Returns for 3 years5.321.99267%
Returns for 5 years36.8132.09115%
Returns for 10 years68.0749.03139%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CBZ81.671.02
+1.26%
CBIZ
BLDR160.12-0.45
-0.28%
Builders FirstSource
WGS79.20-1.30
-1.61%
GeneDx Holdings Corp
PCT11.68-0.20
-1.68%
PureCycle Technologies
AFMD1.51-0.62
-29.11%
Affimed NV